FMR1 and fragile X syndrome: To eliminate the requirement for antibodies, Li et al. [112] inserted the Nano luciferase gene (Nluc) into the endogenous FMR1 gene locus in FXS iPSCs and control H1 ESCs using CRISPR/Cas9 gene editing.